Fundraising FoxCymabay
Newark, US · 5 known investors
Find your way into Cymabay
Sign up to see every warm intro you have to Cymabay
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cymabay team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California that discovers, develops, and delivers medicines across virology, oncology, and inflammation. The company is investing $32 billion in U.S. operations through 2030 to expand its research infrastructure and create domestic jobs.
Founders & leadership
Board
Investors · 5
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$325K disclosed across 1 round · 2015
▶$325KraisedAug 2015 · 2 investors · BiotechnologyRule 506(b)
- Harold Van Wart, Ph. D.Executive Officer, Director
- Carl Goldfischer, M.D.Director
- Pol BoudesExecutive Officer
- Kurt von EmsterDirector
- Hari Kumar, Ph.D.Director
- Charles A. McWherter, Ph. D.Executive Officer
- Louis G. Lange, M.D., Ph.D.Director
- Robert J. WillsDirector
- Sujal ShahExecutive Officer
- Offering amount
- $325K
- Amount sold
- $325K
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Cymabay went on to found or lead other companies.
Frequently asked questions
- What does Cymabay do?
- Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California that discovers, develops, and delivers medicines across virology, oncology, and inflammation. The company is investing $32 billion in U.S. operations through 2030 to expand its research infrastructure and create domestic jobs.
- Who are Cymabay's investors?
- Cymabay's investors include Avoro Capital Advisors, Bay City Capital, Foresite Capital, VantagePoint Capital Partners, Abingworth.
- How much funding has Cymabay raised?
- Cymabay has disclosed $325K raised across 1 round.
- Where is Cymabay headquartered?
- Cymabay is headquartered in Newark, US.